Syk, a nonreceptor type of protein tyrosine kinase widely expressed in hematopoietic cells, is a candidate suppressor gene in human breast cancer. Reduced expression of Syk protein is correlated with poor prognosis, while its overexpression can reduce the malignant phenotype of breast cancer cells.
Protein kinases in human breast cancer
β Scribed by William G. Cance; Edison T. Liu
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Weight
- 863 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tamoxifen, a synthetic antiestrogen, is known for its antitumoral action in vivo; however, it is well accepted that many tamoxifen effects are elicited via estrogen receptor-independent routes. Previously, we reported that tamoxifen induces PKC translocation in fibroblasts. In the present study, we
## Abstract Carbachol (Cch), a muscarinic acetylcholine receptor (mAChR) agonist, increases intracellularβfree Ca^2+^ mobilization and induces mitogenβactivated protein kinase/extracellular signalβregulated kinase (MAPK/ERK) phosphorylation in MCFβ7 human breast cancer cells. Pretreatment of cells
Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr